GO2 for Lung Cancer

What GO2 for Lung Cancer does

GO2 for Lung Cancer is a US-based 501(c)(3) nonprofit organization that provides free patient support services, patient-centered research, and policy advocacy for the lung cancer community. Its service portfolio includes a toll-free HelpLine (1-800-298-2436), a peer-to-peer Phone Buddy program, the Gathering HOPE online community, the Mind Over Matter coping-skills class, the Lung Cancer Living Room® educational series, clinical trial navigation via LungMATCH, and a dedicated healthcare-professional portal at hcp.go2.org. The organization also administers the Centers of Excellence (COE) program, a national network of 593 designated hospitals, academic medical centers, community clinics, and VA facilities recognized for best-in-class lung cancer screening, biomarker testing, and cancer care.

On the research side, GO2 operates the Lung Cancer Registry and conducts patient-centered studies (SUCCEED, INHERIT, Lung Cancer Risk Survey, International Caregiver Survey, SPARK, and SPACEWALK) in collaboration with partners including the Addario Lung Cancer Medical Institute (ALCMI), Memorial Sloan Kettering Cancer Center, and Dana-Farber Cancer Institute. The organization has published 30+ scientific papers since 2019 and engaged 1,165 research participants in the last year. The platform architecture is community- and event-driven, anchored by the annual Lung Cancer Voices Summit in Washington, D.C. (138 legislative meetings, 176 attendees, 30+ states represented in 2025) and the Shine a Light on Lung Cancer® awareness initiative.

GO2's business model is donation- and grant-funded, with revenue streams from individual giving, corporate sponsorships (including 12 major pharma/biotech sponsors of the 2026 Summit), foundation grants, and event-based fundraising such as walk/runs and the Summer Raise Challenge. All services are provided at no cost to patients and caregivers. Advocacy has produced $245M in secured federal lung cancer research funding and contributed to 22 state-level biomarker testing coverage laws. The organization is currently operating with interim co-CEO leadership (Danielle Hicks) and is conducting a formal CEO search through Vetted Solutions.

Name

GO2 for Lung Cancer

Legal name

GO2 for Lung Cancer

Website

https://go2.org

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

GO2 for Lung Cancer is a US-based nonprofit that delivers free patient support, patient-centered research, and policy advocacy services to people affected by lung cancer, caregivers, and healthcare professionals through a national network of 593 Centers of Excellence.

Ownership category

akta.pro rank

Product category

Lung Cancer Patient Support and Advocacy Services

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Thoracic (Lung) Oncology (HLAKAFAL)

akta.pro secondary industries

Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI), Oncology Telemedicine Platforms (HLALAGAH), Oncology Pathways & Precision Medicine Decision Support (HLACAGAH), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Lung cancer support
• Cancer patient advocacy
• Treatment navigation services
• Cancer research programs
• Healthcare professional education

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Donations and Fundraising: As a nonprofit organization, GO2 for Lung Cancer generates revenue primarily through donations from individuals, corporations, and foundations. The organization conducts fundraising campaigns including walk/run events, the Summer Raise Challenge, and direct donation appeals on their website.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Core offering

GO2 for Lung Cancer is a nonprofit organization that provides free direct support services to lung cancer patients and caregivers, including a HelpLine, peer support programs, treatment navigation, and clinical trial matching. It also runs a national network of 593 Centers of Excellence designated healthcare facilities and conducts patient-centered research studies, while leading federal policy advocacy that has secured over $245 million in lung cancer research funding.

Product overview

GO2 for Lung Cancer is a nonprofit organization offering a comprehensive suite of patient support, research, and advocacy programs. The core offerings include direct support services (HelpLine, Phone Buddy peer support, Gathering HOPE online community, Mind Over Matter coping skills program, and Lung Cancer Living Room® educational events), educational resources (video library, downloadable materials, glossary), and research programs (Lung Cancer Registry, clinical trial navigation via LungMATCH, and multiple research studies including SUCCEED, INHERIT, and epidemiological studies). For healthcare professionals, GO2 provides the Centers of Excellence certification program, Global Knowledge Center for Lung Cancer education hub, and the Lung Cancer Navigator Workshop. For advocacy, the organization runs the annual Lung Cancer Voices Summit, the Shine a Light on Lung Cancer® initiative, and provides an Advocacy Toolkit. The portfolio centers on the twin pillars of direct patient support and driving progress through research and policy advocacy.

Differentiator

Problem solved

Functional benefit

Brands

• Addario Lung Cancer Medical Institute (ALCMI): Collaborative research partner/consortium for clinical trials
• Lung Cancer Registry
• Centers of Excellence (COE)
• Lung Cancer Voices Summit
• Shine a Light on Lung Cancer

Products and services

• HelpLine Toll-free phone and email support service staffed by trained specialists providing one-on-one assistance, resources, and program information for lung cancer patients and caregivers.
• Phone Buddy

Quantifiable outcome

• 125,000 uses of free support services across 43 states and 148 countries
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core and minor.

• Addario Lung Cancer Medical Institute (ALCMI)coreStrategic or Co-development PartnerALCMI is GO2's collaborative medical research consortium partner enabling clinical trials that are person-centered and meaningful to the community. Together they execute studies including SPARK (studying KRAS inhibitor resistance) and SPACEWALK (ALK targeted therapy resistance).
• Memorial Sloan Kettering Cancer Center (MSKCC)coreStrategic or Co-development PartnerOngoing collaboration with MSKCC on the Empathic Communication study developing training for doctors in empathic, non-stigmatizing communication, piloted across 16 sites nationwide including 8 GO2 Centers of Excellence.
• Dana-Farber Cancer InstitutecoreStrategic or Co-development PartnerResearch collaboration led by Dr. Mark Awad at Dana-Farber Cancer Institute on the SPARK study investigating treatment resistance in KRAS-positive lung cancer.
• Broward County Community Partners (READY-Lung Study)minorStrategic or Co-development PartnerPartnership with 15+ Broward County organizations including Black Men's Health, Memorial Cancer Institute, Sylvester Comprehensive Cancer Center, Urban League of Broward County, and others to address lung cancer disparities in African American/Black communities.
• AstraZeneca, Merck, AbbVie, Daiichi-Sankyo, Genentech, Grail, Johnson & Johnson, Pfizer, Novocure, Regeneron, Lilly, Natera, Takeda OncologyminorGTM or Marketing Partner2026 Lung Cancer Voices Summit sponsors representing pharmaceutical and biotech companies across the lung cancer treatment landscape.
• Community-based organizations and healthcare institutionscoreStrategic or Co-development PartnerPartnerships with community organizations and healthcare institutions to address gaps in lung cancer research access and bring research opportunities closer to home.
• Top hospitals and academic medical centerscoreStrategic or Co-development PartnerCollaborations with leading academic medical centers in pursuit of research breakthroughs and better outcomes for people diagnosed and living with lung cancer.
• Research and industry sponsorscoreStrategic or Co-development PartnerPartnerships with research and industry sponsors to ensure research studies and clinical trials are designed and carried out considering patient experience and preferences.
• Connors Center for Women's Health and Gender Biology at Brigham and Women's HospitalminorStrategic or Co-development PartnerLong-standing collaboration including work that first identified critical gaps in understanding lung cancer in women and called for a coordinated national response, informing the Women and Lung Cancer Research and Preventive Services Act.
• American Cancer Society Action Network (ACS-CAN)coreStrategic or Co-development PartnerPartnership with ACS-CAN on state-level campaigns to enact biomarker testing coverage laws. 22 states have enacted such laws to date through this collaboration.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cancer Research Institute: Nonprofit funding immunotherapy research broadly. Comparable in research funding role and scientific output, though not lung-cancer-exclusive.
• American Cancer Society: Largest U.S. cancer nonprofit with a broad portfolio across cancer types. Comparable in advocacy and research funding scale but not lung-cancer-exclusive; competes with GO2 for donors and policy attention.
• American Lung Association: The largest U.S. nonprofit focused on lung health, including lung cancer. Comparable to GO2 in advocacy, research funding, and patient education, but operates across all lung diseases (asthma, COPD, etc.) with a much broader mandate.
• International Association for the Study of Lung Cancer (IASLC): Global professional society for thoracic oncology. Comparable to GO2 in serving the lung cancer ecosystem, but focused on clinician/researcher membership rather than direct patient support.
• Prevent Cancer Foundation: Nonprofit focused on cancer prevention and early detection across multiple cancer types. Comparable in advocacy and screening education, with overlapping audiences in early detection messaging.

Regional players

• GO2 Foundation Europe / Lung Cancer Europe (LuCE): European umbrella organization for lung cancer patient advocacy. Comparable mission and program mix (advocacy, patient support), serving a different geography than GO2's primarily U.S. footprint.

Others

• National Lung Cancer Roundtable (American Cancer Society): Coalition focused on lung cancer screening and early detection. Comparable to GO2's Centers of Excellence and screening advocacy, but operates as a multi-stakeholder convener rather than a direct service provider.

Direct peers

• Lung Cancer Research Foundation: Nonprofit exclusively dedicated to funding lung cancer research. Closely comparable to GO2's research funding and advocacy arm, with overlapping donor base and corporate sponsors.
• LUNGevity Foundation: Lung-cancer-focused nonprofit funding research, education, and patient support. Directly comparable to GO2 in mission, target population, and program mix (research grants, patient navigation, advocacy).

Emerging players

• Bonnie J. Addario Lung Cancer Foundation / ALCMI: Founding organization behind GO2 and ongoing research consortium partner. Directly comparable mission and overlapping clinical trial programs; operates more narrowly as a research consortium.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/go2forlungcancr
• Facebookfacebook.com/GO2forLungCancer
• LinkedInlinkedin.com/company/go2forlungcancer
• Instagraminstagram.com/go2forlungcancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GO2 for Lung Cancer